TY - JOUR
T1 - US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials
T2 - Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma
AU - Cliff, Edward R.Scheffer
AU - Russler-Germain, David A.
AU - Joseph Ross Daval, C.
AU - Kesselheim, Aaron S.
PY - 2024/11/20
Y1 - 2024/11/20
N2 - The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma.
AB - The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma.
UR - https://www.scopus.com/pages/publications/85209828699
U2 - 10.1200/JCO.24.00100
DO - 10.1200/JCO.24.00100
M3 - Comment/debate
C2 - 39052948
AN - SCOPUS:85209828699
SN - 0732-183X
VL - 42
SP - 3901
EP - 3904
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 33
ER -